Things categorized as 'Clinical Trial Results'
Shorting Dendreon
In retrospect... not a good idea. Already up 189% today presumably after the short squeeze.
Wyeth and Elan in a World of Pain
Image via Wikipedia A little over a month ago, I wrote a post detailing how I thought the Bapineuzumab trial (which had just ...
Myriad Cancels Flurizan Development
One month after licensing EU rights to Lundbeck for $100M upfront (a deal I crapped on by the way), Myriad has discontinued the development ...
Bapineuzumab Fails Trial
Image via Wikipedia For a drug expected to top $7B in annual sales, even a partial success looks like a failure to me. ...
Rumor Mill: Pfizer Buying MediGene?
The German based, MediGene hit a 52 week high yesterday on rumors that they are in discussions with the drug giant Pfizer. MediGene ...
Icahn Steals The Future of Enzon Pharmaceuticals
Enzon Pharmaceuticals, on the reported urging of uber-investor Carl Icahn, will spin off a NewCo along with the majority of the company's core ...
MS News: Fingolimod (FTY720) Open Label Results and Tysabri PML Data
Last night (and I doubt coincidentally) two promising therapies for MS released positive data. Novartis's fingolimod (FTY720) in a Phase II study extension ...
American College of Cardiology Weekend Roundup
After two days of the American College of Cardiology conference in Chicago a few things to note: - Drug eluting stents actually do work better ...
PDUFA Dates and Black Box Warnings
Like the FDA needs more bad press. The beleaguered drug watchdog has taken hits aplenty over the last few years for more reason that ...